Company overview
Basic information
Company name
Terra Rent, UAB
Company code
306182961
Registered address
Vilnius, Eišiškių Sodų 18-oji g. 11, LT-02194
Registration date
2022-11-25
Company age: 3 y. 11 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Freight transport by road
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
UAB "Terra Rent"
Company code: 306182961
Address: Vilnius, Eišiškių Sodų 18-oji g. 11, LT-02194
Description
This description was generated by artificial intelligence.
Terra Rent, UAB (company code 306182961) is an operational private limited liability company registered on 25 November 2022. The company is classified as private property and is described as a non-financial company controlled by foreign entities, with foreign natural and legal persons holding more than 50% of the authorised capital. Governance is listed as CEO only, and the company is categorised as micro. Its share capital is EUR 33.0K. Terra Rent operates in Vilnius, Vilniaus m. sav., Vilniaus apskr., and its registered activity is freight transport by road (EVRK H.49.41.00). In the latest available financial year, revenue reached EUR 116.9K and the company recorded a net loss of EUR 31.6K, corresponding to a profit margin of -27.0%. This followed a smaller loss of EUR 941 in 2023, indicating a deterioration in performance. At the end of 2024, equity stood at negative EUR 30.0K, liabilities were EUR 108.1K, and total assets were EUR 78.0K. Staffing remained small, with an average of 2 employees in 2025. Average monthly wage data available for 2024 was EUR 832.44.
Download a detailed company report
Make confident decisions with all the information about Terra Rent, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.